Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Neevo is a **prescription prenatal nutritional supplement** formulated specifically for the dietary management of women before, during, and after pregnancy who require additional support for folate-related metabolic needs. It contains the biologically active form of folate (L-methylfolate), along with other key vitamins and minerals: thiamine, riboflavin, niacinamide, pyridoxine, vitamin B12, vitamin C, vitamin D3, vitamin E, calcium, iron, iodide, magnesium, selenium, and docosahexaenoic acid (DHA) from a vegetarian source. Neevo is commonly used in populations at risk for hyperhomocysteinemia, impaired folic acid absorption or metabolism due to MTHFR gene mutations, or increased nutritional demands during pregnancy. It is intended for use under the supervision of a healthcare provider. Its mechanism is nutritional support, providing active vitamins, minerals, and omega-3 fatty acids necessary for perinatal health and fetal development[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Neevo.